Site intended for UK audience


Androbloc® contains the active substance bicalutamide.

Bicalutamide belongs to a group of medicines called antiandrogens. It works by blocking the effects of male hormones, such as testosterone.

Androbloc® 50 mg is used to treat patients with advanced prostate cancer in combination with LHRH analogue therapy or surgical castration.

Androbloc®150 mg is indicated either as sole therapy or adjuvant to radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer at high risk of progression.

Androbloc® 150 mg is also indicated for the treatment of patients with locally advanced, non-metastatic prostate cancer in whom surgical castration or other medical intervention is not considered appropriate or acceptable.

Active substance: Bicalutamide

Strength Pack size
50 mg 30
150 mg 30

Physicians / Pharmacists Login

We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.

Login Physicians / Pharmacists Login